If your download installers and files are gone or missing or you are getting the following message - "There are currently no files for download defined for your account" please see the following:
As you may be aware, PerkinElmer and Revvity are now two separate companies. As part of this transformation, Revvity Signals is required to remove all versions of our software that reference “PerkinElmer” for distribution. If you have purchased a perpetual version of the software that is not the latest version or have an active subscription to an older version of the software, the physical installer will not be available to download from our site after March 25, 2024. Customer Support will not be able to provide access to old installers after March 25, 2024, per legal agreements between PerkinElmer and Revvity.
In order to complete the removal of PerkinElmer branded software installers by March 25, 2024 , installers are already being removed as of March 10, 2024. If you are trying to access downloads that you are entitled to prior to March 25, 2024 and can not find them, please contact Support with the details of the installer(s) you are trying to obtain for assistance.
If you are experiencing a problem not related to this, please see below for additional information.
For example, If you can't find the ChemDraw or ChemOffice download link when you log into the download center or if you see an error message like that shown below:
- No Products are available for download at this time. Please check again later, or,
- Access to the data service from the 'Downloads' page is not available at this time.
- Best performance is found when using Chrome. Some issues may occur when using the MS Edge browser.
Please, try again later, as the outage is most likely a temporary situation.
For ChemDraw Trials: you may be looking for the ChemDraw Trial page, but may not be finding it. You may have bookmarked an older version of the page. In any case, use the following link to access trials:
https://revvitysignals.com/products/research/chemdraw
Comments
0 comments
Article is closed for comments.